![](/img/cover-not-exists.png)
Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)
D.S. ALBERTS, P.Y. LIU, S.P. WILCZYNSKI, A. JANG, J. MOON, J.H. WARD, J.T. BECK, M. CLOUSER, M. MARKMANVolume:
17
Year:
2007
Language:
english
Pages:
5
DOI:
10.1111/j.1525-1438.2007.00882.x
File:
PDF, 92 KB
english, 2007